Old suspect - New evidence: The role of PKCβ in diabetes mellitus-accelerated atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 8, 2013, Pages 1737-1738

  Butcher, Matthew ^a   Galkina, Elena V ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Apoe; Atherosclerosis; Hyperglycemia; Macrophage; PKC ; Type 2 diabetes

Indexed keywords

APOLIPOPROTEIN E; CYTOKINE; DIACYLGLYCEROL; FATTY ACID; GELATINASE A; GLUCOSE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C BETA;

ATHEROGENESIS; ATHEROSCLEROSIS; BONE MARROW; CARDIOVASCULAR RISK; CYTOKINE RELEASE; DISEASE EXACERBATION; DYSLIPIDEMIA; EDITORIAL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; LEUKOCYTE; MACROPHAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RNA TRANSCRIPTION;

APOE; ATHEROSCLEROSIS; HYPERGLYCEMIA; MACROPHAGE; PKCΒ; TYPE 2 DIABETES;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; PROTEIN KINASE C; PROTEIN KINASE C BETA; VASCULITIS;

EID: 84881021191     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.301922     Document Type: Editorial

References (11)

1. Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013;17: 20-33.
2. Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S, King GL. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol. 1993;265: E783-E793.
3. Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res. 2010;106: 1319-1331.
4. Harja E, Chang JS, Lu Y, Leitges M, Zou YS, Schmidt AM, Yan SF. Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis. FASEB J. 2009;23: 1081-1091.
5. Kong L, Shen X, Lin L, Leitges M, Rosario R, Zou YS, Yan SF. PKCβ promotes vascular inflammation and acceleration of atherosclerosis in diabetic ApoE null mice. Arterioscler Thromb Vac Biol. 2013;33: 1779-1787.
6. Harja E, Bucciarelli LG, Lu Y, Stern DM, Zou YS, Schmidt AM, Yan SF. Early growth response-1 promotes atherogenesis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation. Circ Res. 2004;94: 333-339.
7. Albrecht C, Preusch MR, Hofmann G, Morris-Rosenfeld S, Blessing E, Rosenfeld ME, Katus HA, Bea F. Egr-1 deficiency in bone marrowderived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model. Cardiovasc Res. 2010;86: 321-329.
8. Matheus AS, Tannus LR, Cobas RA, Palma CC, Negrato CA, Gomes Mde B. Impact of diabetes on cardiovascular disease: an update. Int J Hypertens. 2013;2013:653789.
9. Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14: 575-585.
10. Mochly-Rosen D, Das K, Grimes KV. Protein kinase C, an elusive therapeutic target? Nat Rev Drug Discov. 2012;11: 937-957.
11. Ladage D, Tilemann L, Ishikawa K, Correll RN, Kawase Y, Houser SR, Molkentin JD, Hajjar RJ. Inhibition of PKCα/β with ruboxistaurin antagonizes heart failure in pigs after myocardial infarction injury. Circ Res. 2011;109: 1396-1400.